BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 25663250)

  • 1. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional supplements and ergogenic AIDS.
    Liddle DG; Connor DJ
    Prim Care; 2013 Jun; 40(2):487-505. PubMed ID: 23668655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of doping. That is relevant for more than Olympic competitors].
    Bischoff M
    MMW Fortschr Med; 2012 Jul; 154(13):23. PubMed ID: 22957374
    [No Abstract]   [Full Text] [Related]  

  • 7. Sports Pharmacology: A Medical Pharmacologist's Perspective.
    Malve HO
    J Pharm Bioallied Sci; 2018; 10(3):126-136. PubMed ID: 30237683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What every physician should know about doping and doping control.
    Lazzoli JK
    Rev Assoc Med Bras (1992); 2016 Apr; 62(2):101-5. PubMed ID: 27167536
    [No Abstract]   [Full Text] [Related]  

  • 9. The sports psychiatrist and performance-enhancing drugs.
    Creado S; Reardon C
    Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Performance-Enhancing Substances.
    LaBotz M; Griesemer BA;
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27354458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances.
    Cadwallader AB; Murray B
    Int J Sport Nutr Exerc Metab; 2015 Aug; 25(4):396-404. PubMed ID: 25675030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Every physician must be familiar with the doping list. Doping classified substances should be avoided for athletes--sometimes dispensation is necessary].
    Eriksson BO
    Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1345-6. PubMed ID: 22913115
    [No Abstract]   [Full Text] [Related]  

  • 13. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nutritional supplements in sports - sense, nonsense or hazard?].
    Parr MK; Schmidtsdorff S; Kollmeier AS
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):314-322. PubMed ID: 28058459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance and Performance Enhancing Drugs and Substances: The Role of the School Nurse.
    Siegmund LA
    NASN Sch Nurse; 2022 Sep; 37(5):263-269. PubMed ID: 35466806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Faster, higher, stronger: knowledge about old and new doping substances].
    Pieters T; de Hon O
    Ned Tijdschr Geneeskd; 2013; 157(28):A6450. PubMed ID: 23841931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national study of substance use behaviors among NCAA male athletes who use banned performance enhancing substances.
    Buckman JF; Farris SG; Yusko DA
    Drug Alcohol Depend; 2013 Jul; 131(1-2):50-5. PubMed ID: 23688842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Educational opportunities and anti-doping roles and responsibilities for pharmacists.
    Ambrose PJ
    Yakugaku Zasshi; 2011; 131(12):1761-4. PubMed ID: 22129874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and misuse of hormones in sport.
    Sonksen PH; Cowan D; Holt RI
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):882-883. PubMed ID: 27542991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.